|
HNRNPH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.36759994626846E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.7612000009245E-08 |
| Normal-vs-Stage2 |
5.613200E-04 |
| Normal-vs-Stage3 |
7.83929998693367E-09 |
| Normal-vs-Stage4 |
3.74010045156581E-10 |
| Stage1-vs-Stage2 |
6.539600E-01 |
| Stage1-vs-Stage3 |
2.106200E-01 |
| Stage1-vs-Stage4 |
5.660100E-03 |
| Stage2-vs-Stage3 |
2.199000E-01 |
| Stage2-vs-Stage4 |
3.441700E-02 |
| Stage3-vs-Stage4 |
1.588630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98210003965471E-09 |
| Normal-vs-AfricanAmerican |
4.981700E-03 |
| Normal-vs-Asian |
1.91442999999403E-05 |
| Caucasian-vs-AfricanAmerican |
3.749800E-01 |
| Caucasian-vs-Asian |
9.783000E-01 |
| AfricanAmerican-vs-Asian |
4.614800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.97440002919814E-10 |
| Normal-vs-Female |
1.50869999826497E-08 |
| Male-vs-Female |
6.504200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.4704000002358E-07 |
| Normal-vs-Age(41-60Yrs) |
7.43439998451834E-09 |
| Normal-vs-Age(61-80Yrs) |
9.04929997602721E-09 |
| Normal-vs-Age(81-100Yrs) |
1.820370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.237800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.242800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.142000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.991400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.328200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.046000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.603400E-01 |
| Classical-VS-Follicular |
2.238000E-02 |
| Classical-VS-Other |
6.891900E-02 |
| Classical-VS-Normal |
2.11230000046747E-07 |
| Tall-VS-Follicular |
9.204400E-01 |
| Tall-VS-Other |
2.598000E-01 |
| Tall-VS-Normal |
1.5925099999925E-05 |
| Follicular-VS-Other |
3.486400E-01 |
| Follicular-VS-Normal |
4.60140000546616E-08 |
| Other-VS-Normal |
9.790900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06019998230767E-09 |
| Normal-vs-N1 |
3.80960000212482E-08 |
| N0-vs-N1 |
1.990350E-01 |
|
|
